Xiangmin Cui

Insider Reports History

Location
Shandong
Signature
/s/ Xiangmin Cui
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Xiangmin Cui:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvation Bio Inc. Director Class A Common Stock 17,062,202 $50,674,740 $2.97 04 Sep 2024 By Decheng Anbio Limited
Nuvation Bio Inc. Director Class A Common Stock 7,611,031 $22,604,762 $2.97 04 Sep 2024 By Decheng Capital Global Healthcare Fund (Master), LP
Nuvation Bio Inc. Director Class A Common Stock 1,281,206 $3,805,182 $2.97 04 Sep 2024 By Decheng Capital China Life Sciences USD Fund III, L.P.
Cue Health Inc. Director Common Stock 788,441 $236,532 $0.3000 28 Sep 2021 Indirect
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 0 $0 $6.33 18 May 2024 Indirect
Nuvation Bio Inc. Director Warrants (Right to Buy) 437,834 03 Sep 2024 By Decheng Anbio Limited
Nuvation Bio Inc. Director Warrants (Right to Buy) 175,346 03 Sep 2024 By Decheng Capital Global Healthcare Fund (Master), LP
Nuvation Bio Inc. Director Warrants (Right to Buy) 32,877 03 Sep 2024 By Decheng Capital China Life Sciences USD Fund III, L.P.
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Stock Option (Right to buy) 0 20 May 2024 Direct
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Warrant (right to buy) 0 18 Jan 2024 Indirect
Cue Health Inc. Director Series C-1 Preferred Stock 0 28 Sep 2021 Indirect
Nuvation Bio Inc. Director Series A Preferred Stock 0 04 Sep 2024 By Decheng Anbio Limited
Nuvation Bio Inc. Director Series A Preferred Stock 0 04 Sep 2024 By Decheng Capital China Life Sciences USD Fund III, L.P.
Nuvation Bio Inc. Director Series A Preferred Stock 0 04 Sep 2024 By Decheng Capital Global Healthcare Fund (Master), LP

Insider Reports Filed by Xiangmin Cui

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NUVB Nuvation Bio Inc. 03 Sep 2024 12 $0 4 Director 05 Sep 2024, 16:15
NUVB Nuvation Bio Inc. 25 Jun 2024 1 +$825,348 4 Director 26 Jun 2024, 16:31
NUVB Nuvation Bio Inc. 20 Jun 2024 3 +$1,492,385 4 Director 25 Jun 2024, 17:45
/report/000162619924000095-cui-xiangmin-2024-05-18 ALPINE IMMUNE SCIENCES, INC. 18 May 2024 8 $0 4 Director, 10%+ Owner 20 May 2024, 20:08
NUVB Nuvation Bio Inc. 09 Apr 2024 3 $0 4 Director 11 Apr 2024, 21:01
NUVB Nuvation Bio Inc. 09 Apr 2024 0 $0 3 Director 11 Apr 2024, 20:58
/report/000120919124002014-cui-xiangmin-2024-01-18 ALPINE IMMUNE SCIENCES, INC. 18 Jan 2024 2 +$15,729,263 4 Director, 10%+ Owner 22 Jan 2024, 17:48
/report/000162619924000010-cui-xiangmin-2024-01-02 ALPINE IMMUNE SCIENCES, INC. 02 Jan 2024 1 $0 4 Director, 10%+ Owner 04 Jan 2024, 19:03
/report/000120919123055208-cui-xiangmin-2023-11-09 ALPINE IMMUNE SCIENCES, INC. 09 Nov 2023 1 +$4,687,500 4 Director, 10%+ Owner 14 Nov 2023, 17:33
/report/000162619923000015-cui-xiangmin-2023-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2023 1 $0 4 Director, 10%+ Owner 05 Jan 2023, 17:55
/report/000120919122051372-cui-xiangmin-2022-09-23 ALPINE IMMUNE SCIENCES, INC. 23 Sep 2022 2 +$14,700,000 4 Director, 10%+ Owner 27 Sep 2022, 16:51
/report/000162619922000004-cui-xiangmin-2022-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2022 1 $0 4 Director, 10%+ Owner 04 Jan 2022, 16:17
/report/000114036121033147-cui-xiangmin-2021-09-28 Cue Health Inc. 28 Sep 2021 3 +$10,092,045 4 Director 30 Sep 2021, 17:43
/report/000114036121032361-cui-xiangmin-2021-09-23 Cue Health Inc. 23 Sep 2021 0 $0 3 Director, 10%+ Owner 23 Sep 2021, 21:06
/report/000162619921000112-cui-xiangmin-2021-09-17 ALPINE IMMUNE SCIENCES, INC. 17 Sep 2021 1 +$14,499,998 4 Director, 10%+ Owner 21 Sep 2021, 17:12